应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
09989 海普瑞
未开盘 05-22 16:08:35
3.580
+0.070
+1.99%
最高
3.650
最低
3.510
成交量
54.95万
今开
3.650
昨收
3.510
日振幅
3.99%
总市值
52.53亿
流通市值
7.88亿
总股本
14.67亿
成交额
195.88万
换手率
0.25%
流通股本
2.20亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
北向资金5月21日净买入海普瑞2.56万股 连续3日增持
自选股智能写手 · 05-22 09:31
北向资金5月21日净买入海普瑞2.56万股 连续3日增持
海普瑞(09989)下跌5.12%,报3.52元/股
金融界 · 05-21 15:29
海普瑞(09989)下跌5.12%,报3.52元/股
海普瑞(09989)股价下跌5.121%,现价港币$3.52
阿斯达克财经 · 05-21 15:29
海普瑞(09989)股价下跌5.121%,现价港币$3.52
北向资金5月16日净卖出海普瑞20.18万股 连续3日减持
自选股智能写手 · 05-17
北向资金5月16日净卖出海普瑞20.18万股 连续3日减持
海普瑞(002399.SZ/9989.HK):2024Q1归母净利润同比增长133%,稳健经营持续向好
格隆汇 · 05-16
海普瑞(002399.SZ/9989.HK):2024Q1归母净利润同比增长133%,稳健经营持续向好
尾盘发力收涨42%,君圣泰医药-B(02511)走出低谷仍言之尚早?
智通财经 · 05-08
尾盘发力收涨42%,君圣泰医药-B(02511)走出低谷仍言之尚早?
海普瑞获融资买入0.18亿元,近三日累计买入0.60亿元
金融界 · 05-08
海普瑞获融资买入0.18亿元,近三日累计买入0.60亿元
海普瑞(002399)5月6日主力资金净买入1500.91万元
证券之星 · 05-07
海普瑞(002399)5月6日主力资金净买入1500.91万元
智通AH统计|5月6日
智通财经 · 05-06
智通AH统计|5月6日
5月3日海普瑞涨停分析:化学原料药,肝素,创新药概念热股
证券之星 · 05-03
5月3日海普瑞涨停分析:化学原料药,肝素,创新药概念热股
海普瑞盘中异动 股价大涨5.03%
自选股智能写手 · 05-02
海普瑞盘中异动 股价大涨5.03%
5月1日海普瑞涨停分析:化学原料药,肝素,创新药概念热股
证券之星 · 05-01
5月1日海普瑞涨停分析:化学原料药,肝素,创新药概念热股
4月30日海普瑞涨停分析:化学原料药,肝素,创新药概念热股
证券之星 · 04-30
4月30日海普瑞涨停分析:化学原料药,肝素,创新药概念热股
海普瑞午盘涨近7% 首季归母净利同比增长1.33倍
新浪港股 · 04-30
海普瑞午盘涨近7% 首季归母净利同比增长1.33倍
港股异动 | 海普瑞(09989)A股涨停 H股一度涨超11% 首季归母净利同比增长1.33倍
智通财经 · 04-30
港股异动 | 海普瑞(09989)A股涨停 H股一度涨超11% 首季归母净利同比增长1.33倍
肝素概念盘中拉升,海普瑞涨停
自选股智能写手 · 04-30
肝素概念盘中拉升,海普瑞涨停
海普瑞9.98%涨停,总市值152.01亿元
金融界 · 04-30
海普瑞9.98%涨停,总市值152.01亿元
异动快报:海普瑞(002399)4月30日9点45分触及涨停板
证券之星 · 04-30
异动快报:海普瑞(002399)4月30日9点45分触及涨停板
海普瑞盘中异动 股价大涨6.17%
自选股智能写手 · 04-30
海普瑞盘中异动 股价大涨6.17%
海普瑞(09989)上涨7.06%,报3.49元/股
金融界 · 04-30
海普瑞(09989)上涨7.06%,报3.49元/股
公司概况
公司名称:
海普瑞
所属市场:
SEHK
上市日期:
--
主营业务:
深圳市海普瑞药业集团股份有限公司是一家中国制药公司。该公司经营四个分部。药物制剂分部从事生产和销售抗凝血及抗血栓药物制剂,包括依诺肝素钠注射液和肝素钠注射液。Active Pharmaceutical Ingredient(API)分部从事生产和销售API产品,包括肝素钠API和依诺肝素钠API。Contract Development Manufacturing Organization(CDMO)分部提供药物开发所需要的全周期服务,包括研发、生产、质量管理、项目管理以及商业化生产。该公司还经营其他分部。
发行价格:
--
{"stockData":{"symbol":"09989","market":"HK","secType":"STK","nameCN":"海普瑞","latestPrice":3.58,"timestamp":1716365315021,"preClose":3.51,"halted":0,"volume":549500,"delay":0,"floatShares":220094500,"shares":1467296204,"eps":-0.5744278,"marketStatus":"未开盘","marketStatusCode":0,"change":0.07,"latestTime":"05-22 16:08:35","open":3.65,"high":3.65,"low":3.51,"amount":1958806,"amplitude":0.039886,"askPrice":3.58,"askSize":18000,"bidPrice":3.57,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":-0.5097029890467639,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1716427800000},"adr":0,"listingDate":1594137600000,"adjPreClose":3.51,"dividendRate":0.030111,"openAndCloseTimeList":[[1716341400000,1716350400000],[1716354000000,1716364800000]],"volumeRatio":0.530405405471962,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"002399","market":"SZ","secType":"STK","nameCN":"海普瑞","latestPrice":9.99,"timestamp":1716361389000,"preClose":10.02,"halted":0,"volume":3038948,"delay":0,"premium":"-66.70"}},"requestUrl":"/m/hq/s/09989/wiki","defaultTab":"wiki","newsList":[{"id":"2437402195","title":"北向资金5月21日净买入海普瑞2.56万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2437402195","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2437402195?lang=zh_cn&edition=full","pubTime":"2024-05-22 09:31","pubTimestamp":1716341463,"startTime":"0","endTime":"0","summary":"5月21日, 北向资金增持海普瑞2.56万股,连续3日增持。截止当日收盘,深股通共持有海普瑞567.95万股,占流通股0.45%。深股通增持金额前五个股分别为宁德时代、平安银行、京东方A、格力电器、新易盛。海普瑞近5个交易日下跌1.57%,深股通累计增持14.86万股;近20个交易日上涨10.60%,深股通累计增持86.02万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522093748878569bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522093748878569bc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2437605804","title":"海普瑞(09989)下跌5.12%,报3.52元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2437605804","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2437605804?lang=zh_cn&edition=full","pubTime":"2024-05-21 15:29","pubTimestamp":1716276577,"startTime":"0","endTime":"0","summary":"5月21日,海普瑞(09989)盘中下跌5.12%,截至15:29,报3.52元/股,成交251.6万元。深圳市海普瑞药业集团股份有限公司是全球最大的肝素钠原料药企业及全球第三大依诺肝素制剂企业,其产品在全球多个国家和地区销售,为公司创造稳定增长的现金流。同时,公司还拥有多个首创新药的全球化资产权益和多个临床中后期品种的大中华区商业化权益,全资收购的生物大分子CDMO公司—Cytovance为公司提供了全球领先的技术体系,使得公司在药品全球研发、快速转化、生产运营、市场营销等方面具有显著优势。截至2024年一季报,海普瑞营业总收入13.73亿元、净利润1.55亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/05/21152940718953.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2437604184","title":"海普瑞(09989)股价下跌5.121%,现价港币$3.52","url":"https://stock-news.laohu8.com/highlight/detail?id=2437604184","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2437604184?lang=zh_cn&edition=full","pubTime":"2024-05-21 15:29","pubTimestamp":1716276540,"startTime":"0","endTime":"0","summary":"[下跌股]海普瑞(09989) 股价在下午03:29比前收市价下跌5.121%,现股价为港币$3.52。至目前为止,今日最高价为$3.73,而最低价为$3.52。总成交量为69.5万股,总成交金额为港币$251.603万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2405213812/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2436393706","title":"北向资金5月16日净卖出海普瑞20.18万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2436393706","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2436393706?lang=zh_cn&edition=full","pubTime":"2024-05-17 09:30","pubTimestamp":1715909457,"startTime":"0","endTime":"0","summary":"5月16日,北向资金减持海普瑞20.18万股连续3日减持。截止当日收盘,深股通共持有海普瑞522.01万股,占流通股0.41%。深股通减持金额前五个股分别为新易盛、万科A、美的集团、天孚通信、科大讯飞。海普瑞近5个交易日下跌2.57%,深股通累计增持48.80万股;近20个交易日上涨17.74%,深股通累计减持27.41万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405170937508b10c2d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405170937508b10c2d7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435690188","title":"海普瑞(002399.SZ/9989.HK):2024Q1归母净利润同比增长133%,稳健经营持续向好","url":"https://stock-news.laohu8.com/highlight/detail?id=2435690188","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2435690188?lang=zh_cn&edition=full","pubTime":"2024-05-16 08:52","pubTimestamp":1715820751,"startTime":"0","endTime":"0","summary":"面对全球肝素行业周期波动时,海普瑞在一季报中展现出强大的韧性","market":"hk","thumbnail":"https://img2.gelonghui.com/41ce6-d2114273-9194-4ad7-9e6d-baaf24929fd7.jpg?guru_height=3771&guru_width=5657","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/41ce6-d2114273-9194-4ad7-9e6d-baaf24929fd7.jpg?guru_height=3771&guru_width=5657"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/737022","is_publish_highlight":false,"gpt_icon":0},{"id":"2433714010","title":"尾盘发力收涨42%,君圣泰医药-B(02511)走出低谷仍言之尚早?","url":"https://stock-news.laohu8.com/highlight/detail?id=2433714010","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433714010?lang=zh_cn&edition=full","pubTime":"2024-05-08 16:39","pubTimestamp":1715157561,"startTime":"0","endTime":"0","summary":"然而,君圣泰医药纳入港股通首日股价大跌18.69%,期间股价累计跌幅达47%。此后君圣泰股价一路向下,截至5月7日,其市值仅剩不到30亿港元。数据显示,2022年和2023年,君圣泰医药的研发投入分别为1.83亿元和3.12亿元。年报显示,2023年海普瑞实现收入54.46亿元,同比下降23.94%;归属于上市公司股东的净亏损达到7.83亿元,同比下降207.68%,为上市以来首次亏损。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1118752.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2433206763","title":"海普瑞获融资买入0.18亿元,近三日累计买入0.60亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433206763","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2433206763?lang=zh_cn&edition=full","pubTime":"2024-05-08 09:21","pubTimestamp":1715131301,"startTime":"0","endTime":"0","summary":"5月7日,沪深两融数据显示,海普瑞获融资买入额0.18亿元,居两市第1011位,当日融资偿还额0.15亿元,净买入381.20万元。最近三个交易日,29日-7日,海普瑞分别获融资买入0.04亿元、0.38亿元、0.18亿元。融券方面,当日融券卖出4.51万股,净买入27.73万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050809215887de4733&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050809215887de4733&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433077265","title":"海普瑞(002399)5月6日主力资金净买入1500.91万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433077265","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2433077265?lang=zh_cn&edition=full","pubTime":"2024-05-07 09:13","pubTimestamp":1715044435,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月6日收盘,海普瑞报收于11.03元,上涨6.47%,换手率2.49%,成交量31.0万手,成交额3.29亿元。近5日资金流向一览见下表:海普瑞融资融券信息显示,融资方面,当日融资买入3783.81万元,融资偿还704.12万元,融资净买入3079.69万元。海普瑞主营业务:肝素产业链、生物大分子CDMO和创新药物的投资、开发及商业化,致力于为全球患者带去高质量的安全有效药物和服务,护佑健康。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050700012091.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433641027","title":"智通AH统计|5月6日","url":"https://stock-news.laohu8.com/highlight/detail?id=2433641027","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433641027?lang=zh_cn&edition=full","pubTime":"2024-05-06 16:15","pubTimestamp":1714983306,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示,截止5月6日收盘,东北电气、弘业期货、浙江世宝分列AH溢价率前三位,溢价率分别为1161.68%、771.43%、582.70%;招商银行、比亚迪股份、紫金矿业分列AH溢价率末三位,溢价率分别为15.89%、19.94%、21.47%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1117512.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2432982949","title":"5月3日海普瑞涨停分析:化学原料药,肝素,创新药概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2432982949","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2432982949?lang=zh_cn&edition=full","pubTime":"2024-05-03 15:11","pubTimestamp":1714720317,"startTime":"0","endTime":"0","summary":"证券之星消息,海普瑞涨停收盘,收盘价10.36元。该股于9点45分涨停,未打开涨停,截止收盘封单资金为5535.59万元,占其流通市值0.43%。该股为化学原料药,肝素,创新药概念热股,当日化学原料药概念上涨2.19%,肝素概念上涨1.51%,创新药概念上涨1.24%。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050300003274.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2432640914","title":"海普瑞盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432640914","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432640914?lang=zh_cn&edition=full","pubTime":"2024-05-02 15:47","pubTimestamp":1714636039,"startTime":"0","endTime":"0","summary":"2024年05月02日临近收盘15时47分,海普瑞股票出现波动,股价大幅拉升5.03%。截至发稿,该股报3.530港元/股,成交量34.35万股,换手率0.16%,振幅7.74%。资金方面,该股资金流入45.356万港元,流出65.6885万港元。海普瑞股票所在的药品行业中,整体涨幅为0.79%。消息层面,截至15时47分,海普瑞股票正面舆情新闻比例4.55%。该信息摘要如下:海普瑞发布2024年第一季度业绩,营业收入13.73亿元,同比增长5.55%;归母净利润1.55亿元,同比增长133%;每股盈利0.1057元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405021547197a57e8e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405021547197a57e8e7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432476548","title":"5月1日海普瑞涨停分析:化学原料药,肝素,创新药概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2432476548","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2432476548?lang=zh_cn&edition=full","pubTime":"2024-05-01 15:14","pubTimestamp":1714547659,"startTime":"0","endTime":"0","summary":"证券之星消息,海普瑞涨停收盘,收盘价10.36元。该股于9点45分涨停,未打开涨停,截止收盘封单资金为5535.59万元,占其流通市值0.43%。该股为化学原料药,肝素,创新药概念热股,当日化学原料药概念上涨2.19%,肝素概念上涨1.51%,创新药概念上涨1.24%。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050100017297.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431361466","title":"4月30日海普瑞涨停分析:化学原料药,肝素,创新药概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2431361466","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431361466?lang=zh_cn&edition=full","pubTime":"2024-04-30 15:41","pubTimestamp":1714462876,"startTime":"0","endTime":"0","summary":"证券之星消息,海普瑞涨停收盘,收盘价10.36元。该股于9点45分涨停,未打开涨停,截止收盘封单资金为5535.59万元,占其流通市值0.43%。4月30日的资金流向数据方面,主力资金净流入1575.69万元,占总成交额18.18%,游资资金净流出597.46万元,占总成交额6.89%,散户资金净流出978.23万元,占总成交额11.29%。近5日资金流向一览见下表:该股为化学原料药,肝素,创新药概念热股,当日化学原料药概念上涨2.19%,肝素概念上涨1.51%,创新药概念上涨1.24%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301544348b654345&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301544348b654345&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431330259","title":"海普瑞午盘涨近7% 首季归母净利同比增长1.33倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2431330259","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2431330259?lang=zh_cn&edition=full","pubTime":"2024-04-30 13:16","pubTimestamp":1714454189,"startTime":"0","endTime":"0","summary":"海普瑞(09989)A股涨停,H股上涨6.75%,现报3.48港元,成交额1908.72万港元。\n 海普瑞发布2024年第一季度业绩,营业收入13.73亿元,同比增长5.55%;归母净利润1.55亿元,同比增长133%。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-04-30/doc-inatqstc0693711.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-04-30/doc-inatqstc0693711.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431389340","title":"港股异动 | 海普瑞(09989)A股涨停 H股一度涨超11% 首季归母净利同比增长1.33倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2431389340","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431389340?lang=zh_cn&edition=full","pubTime":"2024-04-30 10:31","pubTimestamp":1714444309,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,海普瑞(09989)A股涨停,截至发稿,H股涨8.59%,报3.54港元,成交额1243.67万港元。消息面上,海普瑞发布2024年第一季度业绩,营业收入13.73亿元,同比增长5.55%;归母净利润1.55亿元,同比增长133%。公告称,报告期内,公司以做深依诺肝素钠制剂业务各地市场。期内非欧美海外市场销量稳步回暖,销量回升信号明显。同时,公司继续积极寻找机会于亚洲、南美等地区开拓新市场,于报告期内先后取得新西兰及泰国的入准,进一步加强海外市场的布局及建设。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1116060.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431388629","title":"肝素概念盘中拉升,海普瑞涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2431388629","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431388629?lang=zh_cn&edition=full","pubTime":"2024-04-30 09:58","pubTimestamp":1714442325,"startTime":"0","endTime":"0","summary":"04月30日,肝素概念盘中拉升,截至09点58分,肝素概念整体指数上涨1.04%,报735.060点。从个股上来看,该概念的成分股中,海普瑞涨停,千红制药、赛升药业、丰原药业涨幅居前。从资金上来看,截止发稿,肝素概念主力净流入为-2718.93万,其中海普瑞受到资金热捧,主力净流入918.21万;拉长时间线来看,该板块近20日主力资金净流入-4.52亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043009584587e84e62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043009584587e84e62&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431388930","title":"海普瑞9.98%涨停,总市值152.01亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431388930","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2431388930?lang=zh_cn&edition=full","pubTime":"2024-04-30 09:51","pubTimestamp":1714441900,"startTime":"0","endTime":"0","summary":"4月30日,海普瑞盘中9.98%涨停,截至09:45,报10.36元/股,成交6858.35万元,换手率0.54%,总市值152.01亿元。截至3月31日,海普瑞股东户数2.83万,人均流通股5.18万股。2024年1月-3月,海普瑞实现营业收入13.73亿元,同比增长5.55%;归属净利润1.55亿元,同比增长133.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043009514187c19c18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043009514187c19c18&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431800480","title":"异动快报:海普瑞(002399)4月30日9点45分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2431800480","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431800480?lang=zh_cn&edition=full","pubTime":"2024-04-30 09:45","pubTimestamp":1714441529,"startTime":"0","endTime":"0","summary":"证券之星4月30日盘中消息,9点45分海普瑞触及涨停板。目前价格10.36,上涨9.98%。其所属行业化学制药目前上涨。该股为化学原料药,创新药,医药概念热股,当日化学原料药概念上涨0.57%,创新药概念上涨0.33%,医药概念上涨0.28%。4月29日的资金流向数据方面,主力资金净流入0.87万元,占总成交额0.02%,游资资金净流出287.43万元,占总成交额5.9%,散户资金净流入286.57万元,占总成交额5.88%。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000019464.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431715802","title":"海普瑞盘中异动 股价大涨6.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431715802","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431715802?lang=zh_cn&edition=full","pubTime":"2024-04-30 09:37","pubTimestamp":1714441036,"startTime":"0","endTime":"0","summary":"2024年04月30日早盘09时37分,海普瑞股票出现异动,股价急速拉升6.17%。海普瑞股票所在的药品行业中,整体跌幅为0.01%。其相关个股中,泰凌医药、德琪医药-B、海普瑞涨幅较大,振幅较大的相关个股有海普瑞、兆科眼科-B、和黄医药,振幅分别为3.99%、3.85%、3.39%。消息层面,截至09时37分,海普瑞股票正面舆情新闻比例10%。《海普瑞发布第一季度业绩 归母净利润1.55亿元 同比增长133%》资讯为影响海普瑞的重要信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240430093716861ea2ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240430093716861ea2ff&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431804002","title":"海普瑞(09989)上涨7.06%,报3.49元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2431804002","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2431804002?lang=zh_cn&edition=full","pubTime":"2024-04-30 09:32","pubTimestamp":1714440765,"startTime":"0","endTime":"0","summary":"4月30日,海普瑞盘中上涨7.06%,截至09:32,报3.49元/股,成交101.26万元。深圳市海普瑞药业集团股份有限公司是全球最大的肝素钠原料药企业及全球第三大依诺肝素制剂企业,其产品在全球多个国家和地区销售,为公司创造稳定增长的现金流。截至2024年一季报,海普瑞营业总收入13.73亿元、净利润1.55亿元。4月29日,2024财年一季报归属股东应占溢利1.55亿人民币,同比增长133%,基本每股收益0.1057人民币。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/30093240485449.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.2474},{"period":"3month","weight":0.2517},{"period":"6month","weight":-0.0628},{"period":"1year","weight":-0.2094},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0064},{"period":"1month","weight":0.1625},{"period":"3month","weight":0.1465},{"period":"6month","weight":0.0932},{"period":"1year","weight":-0.0121},{"period":"ytd","weight":0.126}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"深圳市海普瑞药业集团股份有限公司是一家中国制药公司。该公司经营四个分部。药物制剂分部从事生产和销售抗凝血及抗血栓药物制剂,包括依诺肝素钠注射液和肝素钠注射液。Active Pharmaceutical Ingredient(API)分部从事生产和销售API产品,包括肝素钠API和依诺肝素钠API。Contract Development Manufacturing Organization(CDMO)分部提供药物开发所需要的全周期服务,包括研发、生产、质量管理、项目管理以及商业化生产。该公司还经营其他分部。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.086695},{"month":2,"riseRate":0.5,"avgChangeRate":0.033287},{"month":3,"riseRate":0.25,"avgChangeRate":-0.076508},{"month":4,"riseRate":0.5,"avgChangeRate":0.037874},{"month":5,"riseRate":0.75,"avgChangeRate":-0.002083},{"month":6,"riseRate":0.333333,"avgChangeRate":0.034694},{"month":7,"riseRate":0,"avgChangeRate":-0.065146},{"month":8,"riseRate":0.25,"avgChangeRate":-0.023829},{"month":9,"riseRate":0,"avgChangeRate":-0.100348},{"month":10,"riseRate":0.25,"avgChangeRate":-0.04992},{"month":11,"riseRate":0.25,"avgChangeRate":0.003644},{"month":12,"riseRate":0.25,"avgChangeRate":-0.022218}],"exchange":"SEHK","name":"海普瑞","nameEN":"HEPALINK"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海普瑞(09989)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海普瑞(09989)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海普瑞,09989,海普瑞股票,海普瑞股票老虎,海普瑞股票老虎国际,海普瑞行情,海普瑞股票行情,海普瑞股价,海普瑞股市,海普瑞股票价格,海普瑞股票交易,海普瑞股票购买,海普瑞股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海普瑞(09989)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海普瑞(09989)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}